A dozen leading drug companies paid US doctors a total of more than $1bn last year, according to fresh data revealing the extent of links between the pharmaceutical industry and prescribers.
The figures, compiled by the consultancy PharmaShine for the Financial Times, highlight the volumes of spending by drug manufacturers, aimed at more than 500,000 doctors, for entertainment, consulting and research, which critics argue risk distorting the prescription of medicines.
http://www.ft.com/cms/s/0/8eb985e0-c133-11e2-9767-00144feab7de.html#axzz2U38P0edT
1 comment:
The thought that doctors are deciding what drugs to prescribe based on pharma perks is very troubling.
Post a Comment